BERLIN — Wearing pressure-sensing smart insoles (SurroSense Rx, Orpyx Medical Technologies) reduced diabetic foot ulcer recurrence by up to 86% in compliant patients in a randomized single-blinded trial in high-risk individuals with type 1 and 2 diabetes … Neil Reeves, PhD, professor of musculoskeletal biomechanics, Manchester Metropolitan University, UK, presented the results here today at the European Association for the Study of Diabetes (EASD) 2018 Annual Meeting …“By using a plantar pressure-sensing smart insole device, the feedback of pressure information in the intervention arm reduces ulcer recurrence by 71%, and furthermore in the compliant patients, this further increased benefit, with an 86% reduction in ulcer recurrence [compared with controls],” he reported … read more